novartis india ltd (HCBA:Mumbai)
Transactions by NOVARTIS INDIA LTD (HCBA) in the last 6 months
GlaxoSmithKline Consumer Pvt Ltd. agreed to acquire OTC division from Novartis India Limited (BSE:500672) for INR 1.1 billion on January 13, 2015. The transaction is subject to the receipt of all applicable legal, antitrust and regulatory approvals, consents, permissions and sanctions as may be necessary from concerned authorities, as well as closing of the global joint venture transaction between Novartis AG and GlaxoSmithKline plc. The transaction was approved by the ...
|No competitor information is available for HCBA.|
|View Industry Companies|